Impact of Platelet Transfusion at Different Doses in Oncohematology Pediatric Inpatients and Outpatients: A Retrospective Study
Pediatric Blood & Cancer · 2025-04 · 72 (4)
DOI: 10.1002/pbc.31550 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 20.01.2025. Verfasst von Pierpaolo Berti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Transfusion Medicine Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy. Hauptthemen laut MEDLINE: Platelet Transfusion, Neoplasms, Thrombocytopenia, Hemorrhage. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute.
Abstract (Originalsprache)
Background
Platelet (PLT) transfusion is an essential strategy to prevent bleeding in children with thrombocytopenia associated to cancer treatment. However, data on optimal pediatric dosing and transfusion thresholds are limited.
Methods
This retrospective study analyzed data from 607 pediatric patients with hematologic malignancies, nonmalignant disorders, and solid tumors who developed hypoproliferative thrombocytopenia during therapy. In the first phase (Objective 1), the effective response to transfusion (ERTR) was assessed following International Collaboration for Transfusion Medicine guidelines (ICTMG), comparing low‐dose (1.1 × 10 11 PLT/m 2 body surface area) transfusions for inpatients and medium dose (2.2 × 10 11 ) for outpatients. Transfusion thresholds were set at less than 10,000/µL versus 10,000–20,000/µL, and overall PLT concentrate consumption was analyzed. The second phase (Objective 2) examined the total number of transfusions per patient, incidence of major bleeding events, and bleeding‐related mortality rates across dosing groups.
Results
ERTR ranged from 65% to 82%, with significantly higher rates in outpatients compared to inpatients. In outpatients with PLT less than 10,000/µL, the medium dose showed no significant advantage over the lower inpatient dose. Similar efficacy was observed between low (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Transfusion Medicine Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
- Transfusion Medicine Unit, Laboratory Department, Azienda Ospedali Riuniti, Ancona, Italy.
- Transfusion Medicine Unit, Giuliano Isontina University Hospital, Trieste, Italy.
- Pneumology Unit, San Giuseppe Moscati Hospital, Taranto, Italy.
- Biostatistics and Bioinformatics Unit, Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
- Oncohematology, Hemopoietic Transplantation, and Cellular Therapies Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
ORCID-Profile: Pierpaolo Berti
Förderung
- Ministero della Salute
Zitieren
APA
Berti, P., Montanari, M., La Raja, M., Giua, R., Terrenato, I., Becilli, M., Paganelli, V., Di Ruscio, V., Deriu, D., D'Agostino, E., Ferruzzi, I., Conte, M., Porzio, O., & Vacca, M. (2025). Impact of Platelet Transfusion at Different Doses in Oncohematology Pediatric Inpatients and Outpatients: A Retrospective Study. Pediatric Blood & Cancer, 72(4). https://doi.org/10.1002/pbc.31550
Vancouver
Berti P, Montanari M, La Raja M, Giua R, Terrenato I, Becilli M, et al. Impact of Platelet Transfusion at Different Doses in Oncohematology Pediatric Inpatients and Outpatients: A Retrospective Study. Pediatric Blood & Cancer. 2025;72(4). doi:10.1002/pbc.31550
BibTeX
@article{Berti2025,
author = {Berti, Pierpaolo and Montanari, Mauro and La Raja, Massimo and Giua, Renato and Terrenato, Irene and Becilli, Marco and Paganelli, Valeria and Di Ruscio, Valentina and Deriu, Daniele and D'Agostino, Eleonora and Ferruzzi, Ilaria and Conte, Marta and Porzio, Ottavia and Vacca, Michele},
title = {Impact of Platelet Transfusion at Different Doses in Oncohematology Pediatric Inpatients and Outpatients: A Retrospective Study},
journal = {Pediatric Blood & Cancer},
year = {2025},
volume = {72},
number = {4},
doi = {10.1002/pbc.31550}
}
EUVIMED